The Centers for Medicare & Medicaid Services (CMS) has temporarily halted new enrollments for hospice and home health care providers in the Medicare program, effective May 13. The six-month moratorium aims to curb fraud, waste, and abuse in what the agency deems high-risk categories.
Immediate Action & Core Facts
The Trump administration, through Vice President JD Vance's anti-fraud task force, announced the nationwide pause. CMS Administrator Dr. Mehmet Oz stated the move would prevent fraudulent providers from exploiting Medicare beneficiaries and taxpayer funds. The freeze allows CMS to review hospice and home health expenditures and develop additional guidance.
Deeper Dive & Context
Fraud Concerns
The administration cited systemic fraud in the hospice and home health sectors, noting the rapid creation of fraudulent businesses. In 2024, Medicare spent $28.3 billion on hospice care for 1.8 million beneficiaries and $16 billion on home health care for 2.7 million patients, according to the Medicare Payment Advisory Commission.
Policy and Political Context
The moratorium follows recent actions against hospice services in California, Georgia, and Ohio. Some states, including Democratic-led California and Minnesota, have been criticized for not adequately addressing fraud. The administration also highlighted new Medicaid work requirements, which critics argue could strain hospitals and reduce coverage.
Industry Response
While the administration emphasizes fraud prevention, some providers and advocates warn the freeze could inadvertently punish law-abiding businesses. The task force plans to announce further policy shifts, including additional oversight measures.
Long-Term Implications
The moratorium may lead to stricter enrollment criteria and increased scrutiny of existing providers. The administration aims to balance fraud prevention with access to care for Medicare beneficiaries.